Izrael - hebrejčina - Ministry of Health

אפריל רשת חנויות בעמ - שיפור מראה העור

Izrael - hebrejčina - Ministry of Health

ברסלויער בע"מ - רופא - הצגה ניתוב ושידור תמונה במוסדות רפואיים

Izrael - hebrejčina - Ministry of Health

pharmatrade ltd. - מומחה - אנלייזר לבדיקות אלייזה

Izrael - hebrejčina - Ministry of Health

pharmatrade ltd. - כלל האוכלוסיה - one step pregnancy test

Izrael - hebrejčina - Ministry of Health

מסטמן מדיקל - רופא - the devices are intended for use by anaesthesiologists in order to create and maintain a patent airway during anaesthesia. the devices come in 7 sizes to suit all patients in which use of a laryngeal airway is indicated. the single-use device is marketed under the trade name ‘lapremiere plus’ and is supplied sterile. the reusable device is marketed under the trade name ‘laencore plus’ and is supplied non-sterile for reprocessing and sterilization by the user. these devices are accompanied by accessories to aid placement and fixation.

Izrael - hebrejčina - Ministry of Health

roche pharmaceuticals (israel) ltd - rituximab - תרכיז להכנת תמיסה לאינפוזיה - rituximab 10 mg/ml - rituximab - rituximab - mabthera is indicated for the following indications: * non-hodgkin’s lymphoma (nhl)mabthera is indicated for the treatment of patients with relapsed or refractory low-grade or follicular, b-cell non-hodgkin’s lymphoma.mabthera is indicated for the treatment of previously untreated patients with low-grade or follicular lymphoma in combination with chemotherapy mabthera is indicated for the treatment of patients with cd20 positive diffuse large b-cell non-hodgkin's lymphoma in combination with chop chemotherapy. mabthera maintenance therapy is indicated for the treatment of follicular lymphoma patients responding to induction therapy. * chronic lymphocytic leukaemia (cll)mabthera in combination with chemotherapy is indicated for the treatment of patients with previously untreated and relapsed/refractory chronic lymphocytic leukaemia. only limited data are available on efficacy and safety for patients previously treated with monoclonal antibodies including mabthera or patients refractory to previous mabthera plu

Izrael - hebrejčina - Ministry of Health

padagis israel agencies ltd, israel - labetalol hydrochloride - טבליה - labetalol hydrochloride 100 mg - labetalol - labetalol - treatment of all grades of hypertension (mild, moderate and severe) when oral antihypertensive therapy is desirable.

Izrael - hebrejčina - Ministry of Health

takeda israel ltd - mifamurtide - powder for suspension for infusion - mifamurtide 4 mg/vial - mifamurtide - mifamurtide - mepact is indicated in children, adolescents and young adults for the treatment of high grade resectable non metastatic osteosarcoma after macroscopically complete surgical resection. it is used in combination with post operative multi-agent chemotherapy. safety and efficacy have been assessed in studies of patients 2 to 30 years of age at initial diagnosis.

Izrael - hebrejčina - Ministry of Health

mesa trade&marketing - רופא - אביזרים לרפואת שיניים

Izrael - hebrejčina - Ministry of Health

cartiheal (2009) ltd. - רופא - agili-c implant is a bi-phasic, porous resorbable tissue regeneration scaffold for the treatment of focal articular cartilage and/or osteochondral defects. it is indicated for cartilage and/or bone repair. the implant serves as a scaffold for cellular and matrix ingrowth. the agili-c implant is expected to biodegrade within 6 – 12 months.